GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (OTCPK:JWCTF) » Definitions » Total Long-Term Liabilities

JWCTF (JW (Cayman) Therapeutics Co) Total Long-Term Liabilities : $6.34 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JW (Cayman) Therapeutics Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. JW (Cayman) Therapeutics Co's Total Long-Term Liabilities for the quarter that ended in Dec. 2024 was $6.34 Mil.

JW (Cayman) Therapeutics Co Total Long-Term Liabilities Historical Data

The historical data trend for JW (Cayman) Therapeutics Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW (Cayman) Therapeutics Co Total Long-Term Liabilities Chart

JW (Cayman) Therapeutics Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial 17.24 19.92 18.11 27.70 6.34

JW (Cayman) Therapeutics Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.11 22.82 27.70 24.05 6.34

JW (Cayman) Therapeutics Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

JW (Cayman) Therapeutics Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of JW (Cayman) Therapeutics Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

JW (Cayman) Therapeutics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (OTCPK:JWCTF) » Definitions » Total Long-Term Liabilities
Comparable Companies
HKSE:06628 HKSE:02185 HKSE:02496 HKSE:02898 HKSE:09939 HKSE:00690 HKSE:01244 HKSE:02257 HKSE:02197 HKSE:02137 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
02126:Hong Kong
Address
No. 699 Zhong Ke Road, 5th Floor, Building B, Pudong New District, Shanghai, CHN
Website
https://www.jwtherapeutics.com
JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.

JW (Cayman) Therapeutics Co Headlines

No Headlines